MLTX
MLTX
KY61559X1045
MoonLake Immunotherapeutics
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
920.85M EUR
1.63B EUR
1.34B EUR
940.7M EUR
Enterprise Value
464.93M EUR
1.25B EUR
1.15B EUR
681.89M EUR
Valuation Multiples
Trailing P/E
--
--
--
--
Forward P/E
-3.25x
--
--
--
Price to Sales
--
--
--
--
Price to Book
2.11x
3.8x
5.29x
3.09x
EV/Revenue
--
--
--
--
EV/EBITDA
-1.75x
--
--
--
Price to FCF (P/FCF)
--
--
--
--
EV/FCF
--
--
--
--
FCF Yield
-14.32%
-13.83%
-16.67%
-16.78%
ende